While there is one oral version of semaglutide currently available on the market, its results have been inferior to the injectable alternatives
Over the last few years, the popularity of taking GLP-1 medications for weight loss has greatly increased
The main findings deduced by the results in this study are as follow: (1) GLP-1 increases RSNA to regulate diuresis and natriuresis in an inhibitory manner, in which the afferent renal nerve activation is potentiated via elevated GLP-1R expression in the renal pelvis of rats with HF
No irritation, no purging, just calm, clear progress
For patients with polypharmacy, comorbid endocrine disease, or family history of thyroid malignancy, in-depth clinical evaluation is essential before GLP-1 initiation